This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shinagawa-ku, JP (2015)
- Tokyo, JP (2017)
Company Filing History:
Years Active: 2015-2017
Title: Innovations by Yoshio Kuno in Pharmaceutical Composition
Introduction
Yoshio Kuno is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that exhibit satisfactory dissolution properties across a wide pH range. His work is characterized by a focus on enhancing the effectiveness of pharmaceutical preparations.
Latest Patents
Yoshio Kuno holds 2 patents that showcase his innovative approach. His latest patents include a pharmaceutical composition designed to provide a preparation that exhibits satisfactory dissolution properties in a wide pH range. This composition is characterized by containing N-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide, along with a pharmacologically acceptable salt or hydrate of this compound. Additionally, it includes one or more species selected from the group consisting of a sugar alcohol and a water-swelling additive.
Career Highlights
Yoshio Kuno is currently associated with Daiichi Sankyo Company, Limited, where he continues to contribute to pharmaceutical innovations. His work has been instrumental in advancing the field and improving patient outcomes through effective drug formulations.
Collaborations
Yoshio has collaborated with esteemed colleagues such as Masazumi Kojima and Hiroaki Nakagami. These collaborations have further enriched his research and development efforts in the pharmaceutical sector.
Conclusion
Yoshio Kuno's contributions to pharmaceutical compositions reflect his dedication to innovation and improvement in drug formulation. His patents and collaborations highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
